•
Jun 30, 2024

Selecta Biosciences Q3 2024 Earnings Report

Total Revenue
$33.4M
Previous year: $6.55M
+410.5%
EPS
-$1.13
Previous year: -$1.8
-37.2%
Gross Profit
$39.3M
Previous year: $6.36M
+517.5%
Cash and Equivalents
$87.2M
Previous year: $79.6M
+9.6%
Free Cash Flow
-$32.6M
Previous year: -$9.22M
+253.3%
Total Assets
$348M
Previous year: $106M
+227.9%

Selecta Biosciences

Selecta Biosciences